Site navigation

Hutton Institute Receives Funding for Genetic Analysis Tech

Elizabeth Greenberg

,

hutton institute
Funding was awarded from Scottish Enterprise, the Biotechnology and Biological Sciences Research Council and Innovate UK’s ICURe Explore programme. 

Scottish scientists at the James Hutton Institute have won £360,000 in funding to commercialise a technology that unlocks how plants and animals modify their genes when faced with disease or environmental change.

Use of the technology offers major advances in medical diagnosis, such as identifying cancers and the development of new crops, by allowing scientists to identify changes in gene activity related to diseases like cancer or reactions too high temperatures or drought.

The technology aims to be commercialised through a new company, SHARP Genomic Analytics, which will be spun out of The James Hutton Institute in Dundee.

It is based on advances software developed by a team at the Hutton, together with Professor John Brown from the University of Dundee, which automates the otherwise highly complex gene sequencing analysis involved in this work.

“Animals and plants have tens of thousands of genes which are turned on or off or up or down in different cells or conditions,” says Prof. Brown. “The challenge that we have addressed is to detect these changes in gene activity, quickly and accurately, using our advanced software.

“Although the technology was developed while working on plant data, it could have far reaching impacts. Studies using this platform have already included research on diabetes, prostate cancer and fat deposition in human, how climate change impacts tropical coral fish, bacterial disease in honey bees and climate stress and disease in crops.”

Dr. Runxuan Zhang, a computational biologist at The James Hutton Institute, added: “Transcriptomics is still a relatively new and highly specialised field, requiring knowledge of bioinformatics and computational analysis.

“Doing this work can take non-specialists months, holding back their vital work. While they get can it done commercially, the costs can be prohibitive. Instead, we can now do it all online and in days if not hours for much less cost.”

The technology will build on analytical software developed by Dr. Wenbin Guo, a bioinformatician at The James Hutton Institute and released in 2019. Since then, it has already been used by over 10,000 people globally.


Recommended


The £360,000 funding, from the first phase of Scottish Enterprise’s High-Growth Spinout Programme, the Biotechnology and Biological Sciences Research Council and Innovate UK’s ICURe Explore programme, will mean the team can offer this advanced analytics capability as an online commercial service to others.

With additional and novel functions, the new software platform aims to be more powerful and easier to use.

“The SHARP Genomic Analytics platform will hugely improve access to transcriptomics and alternative splicing analysis to biologists,” says Dr Runxuan Zhang. “As part of Scottish Enterprise’s High-Growth programme, we’re now mapping out our commercial needs, including staffing, such as software engineers.”

Elizabeth Greenberg

Staff Writer

Latest News

AI

Nvidia Launches Open Secure AI Alliance for AI Safety and Security

AI Business Recruitment

Nearly a Quarter of Orgs Reducing Entry-level Hiring Due to AI Automation

Business

Scottish Businesses Turn to Self-funding as Growth Confidence Dips in H2

Data Finance

Payment Leaders are Struggling to Get Real-time Data